- Coordinator
- Libelium Comunicaciones Distribuidas SL, Spain
- Runs
- 1 July 2024 to 30 June 2027
- Status
- Running
- EU funding
- €2.9m
- Total cost
- €2.9m
- Partners
- 8 organisations in 5 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101145795
What the project is doing
In the project's own words, from its summary on CORDIS.
This project proposes developing, preclinical and clinical validation of a Point of Care (PoC) biosensing platform based on multiplexed field-effect sensor technology based on graphene monolayers functionalized with specific and oriented recognizing biomolecules (BioGFET). This technology will be used for the rapid and remote diagnosis of Ebola infection by titrating specific biomarkers in peripheral blood samples. To strengthen the diagnostic ability and offer a robust differential triage of patients, serological biomarkers specific for the virus and biomarkers specific for infection severity will be analyzed and compared simultaneously (Figure).
Therefore, the final correlation between the achieved parameters will offer a robust and rapid triage of patients, thus, permitting to identify rapidly at the point-of-care potential Ebola outbreaks and offering to physicians a more precise overview of the patient status before knowing the confirming laboratory results. Besides the proposed technology, another key point of this device is represented by its IA-based cloud networking.
In fact, once processed and retrieved, the locally achieved diagnostic results will be transmitted to a central server (for example, located in a General Hospital), processed by a custom-made IA software, and, in case of necessity, a health warning will be sent to all the interconnected platforms, independently to their location.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Libelium Comunicaciones Distribuidas SL | Zaragoza | Spain | Coordinator |
| Institut National De Recherche Biomedicale Du Zaire | Kinshasa Gombe | CD | Participant |
| Bridg Ou | Tallin | Estonia | Participant |
| Medtronic Iberica SA | Madrid | Spain | Participant |
| Universidad Complutense De Madrid | Madrid | Spain | Participant |
| Universidad De Granada | Granada | Spain | Participant |
| University of Ghana | Accra | Ghana | Participant |
| Universita Campus Bio Medico Di Roma | Roma | Italy | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI